Lobbying Activity Report


Organization: AstraZeneca Canada Inc.
Associated registration: 8188-204-31
Lobbying Activity date: 2023-11-22
Arranged a meeting: Yes
Posted date: 2023-12-15

In-house lobbyists who participated in the lobbying activity: Heather McDonald
Kevin McGuire
Ilias Iliopoulos
Senior Public Office Holders who were lobbied in this activity: Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Mitch Moneo, Assistant Deputy Minister
Pharmaceutical, Laboratory & Blood Services Division, Health
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discussions with BC government officials/organizations and elected representative to obtains public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.
  • Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Senior officer who filed this Lobbying Activity Report: Kiersten Combs
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Date Modified: